|
DNA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.03509994914464E-10 |
| Normal-vs-Stage2 |
1.109550E-02 |
| Normal-vs-Stage3 |
1.71085999999265E-05 |
| Normal-vs-Stage4 |
1.325930E-02 |
| Stage1-vs-Stage2 |
2.077400E-01 |
| Stage1-vs-Stage3 |
3.798000E-01 |
| Stage1-vs-Stage4 |
3.863800E-01 |
| Stage2-vs-Stage3 |
4.016800E-01 |
| Stage2-vs-Stage4 |
5.871200E-01 |
| Stage3-vs-Stage4 |
7.484000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.20009999999382E-05 |
| Normal-vs-Asian |
3.024200E-02 |
| Caucasian-vs-AfricanAmerican |
6.988000E-01 |
| Caucasian-vs-Asian |
2.377200E-01 |
| AfricanAmerican-vs-Asian |
4.966600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
4.40259999567871E-08 |
| Male-vs-Female |
4.478000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.95983999999871E-05 |
| Normal-vs-Extreme_Weight |
3.08970000029163E-07 |
| Normal-vs-Obese |
2.36980000001275E-06 |
| Normal-vs-Extreme_Obese |
7.495500E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.934400E-01 |
| Normal_Weight-vs-Obese |
9.686600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.491400E-01 |
| Extreme_Weight-vs-Obese |
6.446800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.153200E-01 |
| Obese-vs-Extreme_Obese |
6.011400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.783300E-04 |
| Normal-vs-Age(41-60Yrs) |
3.24518190097933E-13 |
| Normal-vs-Age(61-80Yrs) |
4.96279684014667E-11 |
| Normal-vs-Age(81-100Yrs) |
7.116400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.145900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.584400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.084700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.086400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.772200E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.176700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.99760216648792E-15 |
| Normal-VS-Type2 PRCC |
2.46329999999961E-05 |
| Normal-VS-KIRP CIMP |
2.495800E-03 |
| Normal-VS-Unclassified PRCC |
1.74669999997157E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.024200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.857200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.958800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.222300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.233000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.237230E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.78550000001976E-06 |
| Normal-vs-N1 |
1.574760E-04 |
| Normal-vs-N2 |
2.774800E-01 |
| N0-vs-N1 |
5.454300E-02 |
| N0-vs-N2 |
9.893200E-01 |
| N1-vs-N2 |
4.511000E-01 |
|
|
